Clinical Trial Update: A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating methods to improve treatment efficacy in high-risk, previously untreated T-cell lymphoma patients. Sponsor: Sun Yat-sen Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: T-cell Lymphoma Adults, Previously Untreated | Phase 3 | Status: UNKNOWN